Purchase this article with an account.
Gaston Gomez Caride, leonardo ferlini, Luciano Perrone, gerardo valvecchia, Marcelo Zas; vitrectomy outcomes for diabetic vitreous hemorrhage. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3342.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the efficacy and safety of 23-gauge transconjunctival sutureless vitrectomy (23-G TSV) in the management of diabetic vitreous hemorrhage in our series.
Single-center, retrospective, noncomparative series of 33 eyes (33 patients) with diabetic vitreous hemorrhage. All patients underwent pars plana 23-gauge vitrectomy, endolaser panphotocoagulation and perfluoropropane gas (C3F8) was used in all cases, peeling was performed in three cases. All patients had at least 6-month follow-up. Main outcome measures included visual acuity (VA), intraocular pressure (IOP), and intraoperative and postoperative complications.
Mean overall VA was 0,062 Decimal (0.001 to 0.4) preoperatively and 0,229 Decimal (range 0.001 to 0.8) postoperatively. Mean IOP was 15 (range 10-23 mmHg) preoperatively and 15.7 mmHg (range 5-26 mmHg) at 6 months postoperatively. Concerning complications, rhegmatougenous retinal detachment occurred in two eyes and one patient presented hipotony (5 mmhg) one month after surgery.
23-gauge transconjunctival sutureless vitrectomy offers a safe surgical technique and with fewer intraoperative complications been feasible for the treatment for diabetic vitreous hemorrhage
This PDF is available to Subscribers Only